Sustained Stimulation of β₂AR Inhibits Insulin Signaling in H9C2 Cardiomyoblast Cells Through the PKA-Dependent Signaling Pathway

References

• Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–69. doi:10.1136/postgradmedj-2015-133281
   PubMed Web of Science ®Google Scholar
• Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2018.
   Google Scholar
• Wu CS, Hsu LY, Wang SH. Association of depression and diabetes complications and mortality: a population-based cohort study. Epidemiol Psychiatr Sci. 2020;29.
   Google Scholar
• Haeusler RA, Mcgraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2017.
   PubMedGoogle Scholar
• Titchenell PM, Lazar MA, Birnbaum MJ. Unraveling the regulation of hepatic metabolism by insulin. Trends Endocrinol Metab. 2017.
   PubMedGoogle Scholar
• Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6(1):231. doi:10.1101/cshperspect.a009191
   Google Scholar
• Lewis C. The phosphoinositide 3-kinase pathway. Science. 2002.
   Google Scholar
• Leslie M. The insulin receptor substrate (IRS) proteins. Cell Cycle. 2011;10(11):1750–1756. doi:10.4161/cc.10.11.15824
   PubMedGoogle Scholar
• O’Neill B, Abel E. Akt1 in the cardiovascular system: friend or foe? J Clin Invest. 2005;115(8):2059–2064. doi:10.1172/JCI25900
   PubMedGoogle Scholar
• Cullen MT, Brice E, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7(2):85–96. doi:10.1038/nrm1837
   PubMedGoogle Scholar
• Chen Y, Huang L, Qi X, Chen C. Insulin receptor trafficking: consequences for insulin sensitivity and diabetes. Int J Mol Sci. 2019;20(20):5007. doi:10.3390/ijms20205007
   PubMedGoogle Scholar
• Boothe T, Lim GE, Cen H, et al. Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells. Mol Metab. 2016;5(5):366–378. doi:10.1016/j.molmet.2016.01.009
   PubMedGoogle Scholar
• Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab. 2007.
   PubMedGoogle Scholar
• Holman GD, Cushman SW. Subcellular localization and trafficking of the GLUT4 glucose transporter isoform in insulin-responsive cells. Bioessays. 2010;16(10):753–759. doi:10.1002/bies.950161010
   Google Scholar
• Vlavcheski F, Baron D, Vlachogiannis I, MacPherson R, Tsiani E. Carnosol increases skeletal muscle cell glucose uptake via ampk-dependent glut4 glucose transporter translocation. Int J Mol Sci. 2018;19(5):1321. doi:10.3390/ijms19051321
   PubMedGoogle Scholar
• Fu Q, Xu B, Liu Y, et al. Insulin inhibits cardiac contractility by inducing a gi-biased 2-adrenergic signaling in hearts. Diabetes. 2014;63(8):2676–2689. doi:10.2337/db13-1763
   PubMedGoogle Scholar
• Fu Q, Shi Q, West TM, Xiang YK. Cross-talk between insulin signaling and GPCRs. J Cardiovasc Pharmacol. 2017;70(2):74–86. doi:10.1097/FJC.0000000000000481
   PubMedGoogle Scholar
• Maja M, Drinovec L, Glisic S, et al. Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics. PLoS One. 2014;9(11):e112664. doi:10.1371/journal.pone.0112664
   PubMedGoogle Scholar
• Mangmool S, Denkaew T, Phosri S, et al. Sustained βAR stimulation mediates cardiac insulin resistance in a PKA-dependent manner. Mol Endocrinol. 2016;30(1):118. doi:10.1210/me.2015-1201
   PubMedGoogle Scholar
• Mangmool S, Denkaew T, Parichatikanond W, Kurose H. β-adrenergic receptor and insulin resistance in the heart. Biomol Ther (Seoul). 2017;25(1):44–56. doi:10.4062/biomolther.2016.128
   PubMedGoogle Scholar
• Jost P, Fasshauer M, Kahn CR, et al. Atypical β-adrenergic effects on insulin signaling and action in β3-adrenoceptor-deficient brown adipocytes. Am J Physiol Endocrinol Metab. 2002;283(1):E146–153. doi:10.1152/ajpendo.00531.2001
   PubMedGoogle Scholar
• Morisco C, Condorelli G, Trimarco V. Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res. 2005;96(2):180–188. doi:10.1161/01.RES.0000152968.71868.c3
   PubMedGoogle Scholar
• Sergey D, Hsien-Yu WH, Malbon CC. Insulin stimulates phosphorylation of the β2-adrenergic receptor by the insulin receptor, creating a potent feedback inhibitor of its tyrosine kinase. J Biol Chem. 2002;277(12):10698–10703. doi:10.1074/jbc.M109432200
   PubMedGoogle Scholar
• Ciccarelli M, Chuprun JK, Rengo G, et al. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation. 2011;123(18):1953–1962. doi:10.1161/circulationaha.110.988642
   PubMed Web of Science ®Google Scholar
• Wang Z, Gerstein M, Snyder M. RNA-seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57–63. doi:10.1038/nrg2484
   PubMed Web of Science ®Google Scholar
• Stefano GB. Comparing bioinformatic gene expression profiling methods: microarray and RNA-seq. Med Sci Monit Basic Res. 2014;20:138–142. doi:10.12659/msmbr.892101
   PubMedGoogle Scholar
• Shanrong Z, Wai-Ping F-L, Anton B. Comparison of RNA-seq and microarray in transcriptome profiling of activated T cells. PLoS One. 2014;9. 10.1371/journal.pone.0078644.
   Google Scholar
• Fu X, Fu N, Guo S, et al. Estimating accuracy of RNA-SEQ and microarrays with proteomics. BMC Genom. 2009;10(1):161. doi:10.1186/1471-2164-10-161
   PubMedGoogle Scholar
• Chan YK, Sung HK, Jahng JW, Kim GH, Han M, Sweeney G. Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells. Mol Cell Endocrinol. 2016.
   PubMedGoogle Scholar
• Xue-Jie LI, Xiao-Fang S, Feng-Ling W. MiR-291b-3p regulates activation of insulin signal pathway in H9C2 cell. Chin J Lab Diagn. 2016.
   Google Scholar
• Wen G. International Conference; 2017.
   Google Scholar
• Yu G, Wang LG, Han Y, He Q. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Buday L, Drinovec L, Glisic S, et al. Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics. PLoS One. 2014;9(11):e112664. doi:10.1371/journal.pone.0112664
   PubMedGoogle Scholar
• Cipolletta E, Campanile A, Santulli G, et al. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. Cardiovasc Res. 2009;84(3):407–415. doi:10.1093/cvr/cvp252
   PubMedGoogle Scholar
• Kim S, Jee K, Kim D, Koh H, Chung J. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J Biol Chem. 2001;276(16):12864. doi:10.1074/jbc.M001492200
   PubMedGoogle Scholar
• Liguang L, Julie U, Fernando RN, Altschuler D. cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b. J Biol Chem. 2002;277(36):32799–32806. doi:10.1074/jbc.M201491200
   PubMedGoogle Scholar
• Zhiping W, Dillon TJ, Pokala V, et al. Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol. 2006;26(6):2130–2145. doi:10.1128/MCB.26.6.2130-2145.2006
   PubMedGoogle Scholar
• Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem. 2000;275(12):9047. doi:10.1074/jbc.275.12.9047
   PubMed Web of Science ®Google Scholar
• Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420(6913):333–336. doi:10.1038/nature01137
   PubMed Web of Science ®Google Scholar
• Nguyen MTA, Satoh H, Favelyukis S, et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem. 2005;280(42):35361–35371. doi:10.1074/jbc.M504611200
   PubMed Web of Science ®Google Scholar
• Yang R, Trevillyan J. c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol. 2008;40(12):2702–2706. doi:10.1016/j.biocel.2008.06.012
   PubMed Web of Science ®Google Scholar
• Belov AA, Mohammadi M. Grb2, a double-edged sword of receptor tyrosine kinase signaling. Sci Signal. 2012;5(249):pe49–pe49. doi:10.1126/scisignal.2003576
   PubMedGoogle Scholar
• Lin C, Melo F, Ghosh R, et al. Inhibition of basal FGF receptor signaling by dimeric Grb2. Cell. 2012;149(7):1514–1524. doi:10.1016/j.cell.2012.04.033
   PubMed Web of Science ®Google Scholar
• Skolnik EY, Lee CH, Batzer A, et al. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 1993.
   PubMedGoogle Scholar
• Bisson N, James DA, Ivosev G, et al. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat Biotechnol. 2011;29(7):653–658. doi:10.1038/nbt.1905
   PubMed Web of Science ®Google Scholar
• Depetris RS, Hu J, Gimpelevich I, Holt LJ, Daly RJ, Hubbard SR. Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14. Mol Cell. 2005;20(2):325–333. doi:10.1016/j.molcel.2005.09.001
   PubMedGoogle Scholar
• Carré N, Goenaga D, Burnol AF. Modulation of insulin sensitivity by the Grb7 family of molecular adaptors. Obésité. 2011;6(2):114. doi:10.1007/s11690-011-0280-y
   Google Scholar
• Nouaille S, Blanquart C, Zilberfarb V, et al. Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptor. EMBO Rep. 2006;7(5):512–518. doi:10.1038/sj.embor.7400668
   PubMedGoogle Scholar
• Ramos F, Langlais P, Hu D, Dong L, Liu F. Grb10 mediates insulin-stimulated degradation of the insulin receptor: a mechanism of negative regulation. Am J Physiol Endocrinol Metab. 2006;290(6):E1262–1266. doi:10.1152/ajpendo.00609.2005
   PubMed Web of Science ®Google Scholar
• Wick KR, Werner ED, Langlais P, et al. Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. J Biol Chem. 2003;278(10):8460–8467. doi:10.1074/jbc.M208518200
   PubMed Web of Science ®Google Scholar
• Ding X, Iyer R, Novotny C, et al. Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction. Sci Rep. 2020;10(1):3417. doi:10.1038/s41598-020-60290-1
   PubMed Web of Science ®Google Scholar
• Gril B, Vidal M, Assayag F, et al. Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel. Int J Cancer. 2010;121(2):407–415. doi:10.1002/ijc.22674
   Google Scholar
• Zhang Y, Xu G, Liu G, et al. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochem Biophys Res Commun. 2016;476(4):607–613. doi:10.1016/j.bbrc.2016.06.006
   PubMed Web of Science ®Google Scholar
• Ijaz M, Shahbaz M, Jiang W, Fathy AH, Shan WF. The role of Grb2 in cancer and peptides as Grb2 antagonists. Protein Pept Lett. 2017;25.
   Google Scholar
• Neelankal John A, Ram R, Jiang F-X. RNA-seq analysis of islets to characterise the dedifferentiation in type 2 diabetes model mice db/db. Endocr Pathol. 2018;29(3):207–221. doi:10.1007/s12022-018-9523-x
   PubMedGoogle Scholar
• Li X, Lin Z, Zhan X, et al. RNA-seq analysis of the transcriptome of the liver of cynomolgus monkeys with type 2 diabetes. Gene Int J Focus Gene Cloning Gene Struct Funct. 2018.
   Google Scholar
• Satoh JI, Kino Y, Niida S. MicroRNA-seq data analysis pipeline to identify blood biomarkers for alzheimer’s disease from public data. Biomark Insights. 2015.
   PubMedGoogle Scholar
• Sutherland GT, Janitz M, Kril JJ. Understanding the pathogenesis of Alzheimer’s disease: will RNA-Seq realize the promise of transcriptomics? J Neurochem. 2015;116.
   Google Scholar
• Li J-W, Lee HM, Wang Y, et al. Interactome-transcriptome analysis discovers signatures complementary to GWAS Loci of type 2 diabetes. Sci Rep. 2016;6. doi:10.1038/srep35228
   Google Scholar
• Sachs S, Bastidas-Ponce A, Tritschler S, et al. Targeted pharmacological therapy restores β-cell function for diabetes remission. Nat Metab. 2020;2(2):192–209. doi:10.1038/s42255-020-0171-3
   PubMedGoogle Scholar